Intra-monocyte Pharmacokinetics of Imiglucerase Supports a Possible Personalized Management of Gaucher Disease Type 1
Contributeurs/tricesBerger, Juliette; Vigan, Marie; Pereira, Bruno; Nguyen, Thu Thuy; Froissart, Roseline; Belmatoug, Nadia; Dalbiès, Florence; Masseau, Agathe; Rose, Christian; De Roux Serratrice, Christine ; Pers, Yves-Marie; Bertchansky, Ivan; Camou, Fabrice; Bengherbia, Monia; Bourgne, Céline; Caillaud, Catherine; Pettazzoni, Magali; Berrahal, Amina; Stirnemann, Jérôme; Mentré, France; Berger, Marc G
Publié dansClinical Pharmacokinetics, vol. 58, no. 4, p. 469-482
Date de publication2019
Résumé
Mots-clés
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Child
- Enzyme Replacement Therapy
- Female
- Gaucher Disease/drug therapy/metabolism
- Glucosylceramidase/metabolism/pharmacokinetics/therapeutic use
- Humans
- Male
- Middle Aged
- Models, Biological
- Monocytes/metabolism
- Precision Medicine
- Young Adult
Groupe de recherche
Citation (format ISO)
BERGER, Juliette et al. Intra-monocyte Pharmacokinetics of Imiglucerase Supports a Possible Personalized Management of Gaucher Disease Type 1. In: Clinical Pharmacokinetics, 2019, vol. 58, n° 4, p. 469–482. doi: 10.1007/s40262-018-0708-8
Fichiers principaux (1)
Article (Published version)
Fichiers secondaires (1)
Identifiants
- PID : unige:146598
- DOI : 10.1007/s40262-018-0708-8
- PMID : 30128966
ISSN du journal0312-5963